Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A trial of benzhydrocodone in patients with acute pain

Next Previous
X
Search
Trial Profile

A trial of benzhydrocodone in patients with acute pain

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 24 Mar 2023

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Benzhydrocodone (Primary)
  • Indications Acute pain
  • Focus Therapeutic Use

    • Most Recent Events

    • 22 Feb 2023 According to a KemPharm media release, KemPharm has changed its name to Zevra Therapeutics.
    • 29 Nov 2016 According to KemPharm media release, Investigational New Drug (IND) application for KP201/IR has been accepted by the U.S. Food and Drug Administration (FDA) and remain on target for a potential submission in 2018 of the KP201/IR New Drug Application (NDA) and remain on target for a potential submission of New Drug Application (NDA) in 2018.
    • 25 Oct 2016 According to a KemPharm media release, the company has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for KP-201.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top